BAFF variants and methods thereof
US7553930B2 · kind B2 · utility
4Cited by
49References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2004 |
| Grant date | Jun 30, 2009 |
| Priority date | — |
| Expiry date | Dec 20, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel proteins with BAFF dominant negative antagonist, receptor antagonist activity and agonist activity and nucleic acids encoding these proteins. The invention further relates to the use of the novel proteins in the treatment of BAFF or APRIL-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.